7.040USD-1.95%Mkt Cap: 358.08M USDP/E: 14.66Last update: 2026-06-01
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. It offers NERLYNX, an oral version of n…
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap358.08M USD
Enterprise Value279.10M USD
Revenue (TTM)227.18M USD
Gross Profit170.21M USD
Net Income (TTM)31.11M USD
Revenue/Share4.514 USD
Last Price7.040 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees179
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)14.66
P/E (Forward)20.49
PEG—
EV/EBITDA7.08
EV/Revenue1.23
P/S1.61
P/B2.84
EPS (TTM)0.48
EPS (Forward)0.35
52W Range
3.03082% of range7.900
52W High7.900 USD
52W Low3.030 USD
Profitability
Gross Margin74.53%
Oper. Margin-8.54%
EBITDA Margin17.35%
Profit Margin13.62%
ROE23.87%
ROA14.38%
Growth
Revenue Growth-2.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF41.80M USD
CapEx (TTM)71.00K USD
FCF Margin19.41%
FCF Yield12.31%
Net Debt-85.59M USD
Net Debt/EBITDA-2.17
Balance Sheet
Debt/Equity0.22
Current Ratio2.38
Quick Ratio2.14
Book Value/Sh2.524 USD
Cash/Share1.995 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)5.000 USD
Target Range5.000 USD – 5.000 USD
# Analysts1
Ownership
Shares Out.50.90M
Float39.09M
Insiders15.38%
Institutions77.52%
Short Interest
Short Ratio14.5d
Short % Float9.67%
Short % Out.8.24%
Shares Short4.19M
Short (prev mo.)4.16M
Technical
SMA 507.072 (-0.4%)
SMA 2005.982 (+17.7%)
Beta1.23
S&P 52W Chg27.70%
Avg Vol (30d)245.17K
Avg Vol (10d)198.09K
Technical Indicators
RSI (14)50.6
MACD-0.0069
MACD Signal-0.0111
MACD Hist.+0.0042
BB Upper7.613 USD
BB Middle7.188 USD
BB Lower6.763 USD
BB Width11.83%
ATR (14)0.2852 USD
Vol Ratio (20d)0.46x